Clinical Trial Detail

NCT ID NCT01661400
Title Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

rhabdomyosarcoma

childhood brain stem glioma

brain glioma

Ewing sarcoma

Ewing sarcoma of bone

extraosseous Ewing sarcoma

Advanced Solid Tumor

nephroblastoma

spinal cord glioma

childhood medulloblastoma

malignant glioma

pediatric ependymoma

retinoblastoma

Therapies

Cyclophosphamide

Thalidomide

Age Groups: adult child

No variant requirements are available.